Viewing Study NCT03293732


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-02-20 @ 12:39 PM
Study NCT ID: NCT03293732
Status: COMPLETED
Last Update Posted: 2020-01-07
First Post: 2017-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults
Sponsor: Advagene Biopharma Co. Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DCB07030-CT-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View